| Trial name | Trial population | Age range (years) | Outcome measures | No. of outcomes | Time points post-randomisation | No. of time points | No. of correlations | Sample size at baseline | Max Na | Reference | Year of publication |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Leg Ulcer | Leg ulcers | 32 to 97 | EQ-5D, SF-36 | 9 | 3, 12 months | 2 | 18 | 233 | 200 | [9] | 1998 |
2 | NAMEIT | Early severe rheumatoid arthritis | 18 to 75 | SF-36, SF-6D | 9 | 2, 4, 6, 8, 10, 12 months | 6 | 54 | 222 | 222 | [10] | 2000 |
3 | Homeopathy for CFS | Chronic fatigue syndrome (CFS) | 20 to 62 | MFI | 5 | 6 months | 1 | 5 | 103 | 85 | [11] | 2004 |
4 | Acupuncture | Low back pain | 20 to 64 | SF-36 | 8 | 3, 12, 24 months | 3 | 24 | 239 | 217 | [12] | 2005 |
5 | Knee Replacement | Osteoarthritis patients undergoing total knee replacement | 51 to 92 | SF-36, WOMAC | 14 | 3 months | 1 | 14 | 151 | 114 | [13] | 2005 |
6 | FED | Older (aged ≥ 65) hospitalised patients with acute illness | 65 to 93 | Barthel, SF-36 | 9 | 1.5, 6 months | 2 | 18 | 445 | 225 | [14] | 2006 |
7 | AIM-High | Malignant melanoma | 18 to 77 | EORTC QLQ-C30 | 15 | 6, 12, 18, 24 months | 4 | 60 | 444 | 392 | [15] | 2006 |
8 | PoNDER | New mothers | 18 to 45 | CORE-OM, EPDS,b SF-36, SF-6D | 9 | 4.5, 10.5, 16.5 months | 3 | 26 | 2659 | 2659 | [16] | 2009 |
9 | COPD | Chronic obstructive pulmonary disease (COPD) | 49 to 86 | EQ-5D, SF-36, SF-6D | 12 | 2, 6, 12, 18 months | 4 | 48 | 238 | 172 | [17] | 2010 |
10 | Corn Plasters | Foot corns | 18 to 90 | EQ-5D, EQ-5D VAS, VAS Pain | 3 | 3, 6, 9, 12 months | 4 | 12 | 201 | 182 | [18] | 2013 |
11 | PLINY | Independently living older people (aged ≥ 75) | 75 to 95 | EQ-5D, EQ-5D VAS, GSES, ONS Well-being, PHQ-9, SF-36 | 15 | 6 months | 1 | 15 | 157 | 56 | [19] | 2014 |
12 | 3Mg | Adults with acute severe asthma in the emergency department | 16 to 88 | EQ-5D | 1 | 1 month | 1 | 1 | 932 | 437 | [20] | 2014 |
13 | SELF | Shoulder rotator cuff tendinopathy | 23 to 83 | SPADI | 3 | 3, 6, 12 months | 3 | 9 | 85 | 59 | [6] | 2016 |
14 | BEADS | Post-stroke depression | 31 to 97 | EQ-5D, EQ-5D VAS, PHQ-9 | 3 | 6 months | 1 | 3 | 49 | 39 | [21] | 2016 |
15 | DiPALS | Amyotrophic lateral sclerosis (ALS) | 23 to 83 | EQ-5D, SAQLI, SF-36 | 13 | 2, 3, 6, 9, 12 months | 5 | 65 | 74 | 55 | [22] | 2016 |
16 | Lifestyle Matters | Independently living older people (aged ≥ 65) | 65 to 92 | EQ-5D, EQ-5D VAS, GSES, PHQ-9, SF-36 | 14 | 6, 24 months | 2 | 28 | 288 | 262 | [23] | 2017 |
17 | IPSU | Women with urinary incontinence and sexual dysfunction | 21 to 70 | EQ-5D, PISQ-31, SF-36 | 15 | 6 months | 1 | 15 | 107 | 66 | [24] | 2018 |
18 | POLAR | Lumbar radicular syndrome (LRS) | 23 to 71 | Back Pain VAS, EQ-5D, EQ-5D VAS, Leg Pain VAS, ODI | 5 | 1.5, 3, 6 months | 3 | 15 | 80 | 73 | [25] | 2018 |
19 | PRACTICE | COPD | 40 to 92 | EQ-5D, EQ-5D VAS | 2 | 0.25, 1, 3 months | 3 | 6 | 55 | 42 | [26] | 2018 |
20 | STEPWISE | Schizophrenia | 18 to 71 | B-IPQ, BPRS, EQ-5D, EQ-5D VAS, PHQ-9, RAND SF-36 | 14 | 3, 12 months | 2 | 28 | 412 | 358 | [27] | 2018 |
 |  |  |  |  |  |  |  | 464 | 7173 | 5915 |  |  |